Biogen Inc. (NASDAQ: BIIB) and partner Eisai Co. Ltd.
September 19, 3:03 PM
HC Wainwright assumes coverage on Immunic Inc (NASDAQ:IMUX), a late-stage clinical biotech company developing oral small molecule inhibitors for multiple sclerosis (MS)…
September 19, 10:40 AM
The European Commission approved Roche Holding AG’s (OTC:RHHBY) Vabysmo (faricimab) for neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…
September 13, 2:01 PM
Chardan initiated coverage on Outlook Therapeutics Inc (NASDAQ: OTLK) with a Buy rati
August 25, 2:45 PM
Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).
August 16, 2:59 PM
Roche Holdings AG (OTC:RHHBY) announced that the FDA accepted its supplemental marketing application for Polivy. Polivy is being developed by Roche…